跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Kligflow - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Kligflow
Approved
STANDARD
Kligflow
Sapphire Lifesciences Pvt. Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c4c1bd1e382480dc
Company
Sapphire Lifesciences Pvt. Ltd
Type
Standard
Approval Details
Approval Id
c4c1bd1e382480dc
Drug Approval Philippines Name
Kligflow
Product Name
Kligflow
Registration Number
DRP-11849-02
Brand Name
Kligflow
Generic Name
Dutasteride + Tamsulosin Hydrochloride
Dosage Form
Capsule
Dosage Strength
500 mcg/400 mcg
Manufacturer
Sapphire Lifesciences Pvt. Ltd
Importer
Nelpa Lifesciences Inc.
Distributor
Ambitech Biopharmaceuticals Inc
Issuance Date
26 February 2024
Expiry Date
10 May 2027
Pharmacologic Category
Alpha-adrenoreceptor Antagonists
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c4c1bd1e382480dc
Type
Standard
Back to Philippines FDA Approvals